Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,362,834
Closed -$13.2M 249
2023
Q4
$13.2M Sell
2,362,834
-43,880
-2% -$252K 0.57% 71
2023
Q3
$12.8M Buy
2,406,714
+145,163
+6% +$1.18M 0.62% 74
2023
Q2
$21.2M Buy
2,261,551
+447,983
+25% +$3.93M 0.93% 46
2023
Q1
$15.7M Sell
1,813,568
-27,770
-2% -$245K 0.75% 58
2022
Q4
$13M Sell
1,841,338
-13,054
-0.7% -$110K 0.63% 72
2022
Q3
$18.4M Buy
1,854,392
+11,153
+0.6% +$101K 0.95% 44
2022
Q2
$13.2M Buy
1,843,239
+518,452
+39% +$3.78M 0.68% 62
2022
Q1
$12.3M Buy
1,324,787
+1,260,697
+1,967% +$9.49M 0.47% 81
2021
Q4
$599K Buy
+64,090
New +$595K 0.02% 184

Other funds holding DCGO

Emerald Advisers's DCGO Position: Q1 2024 in Review

Emerald Advisers sold out of DocGo (DCGO) in Q1 2024, closing a stake of 2,362,834 shares — an estimated $13.2M sold.

Emerald Advisers first reported a position in DCGO in Q4 2021 and held it in 9 quarters. The position peaked at $21.2M in Q2 2023. 134 funds tracked by Wall St. Rank hold DCGO as of Q1 2024.

  • Emerald Advisers reported no remaining DocGo position as of Q1 2024 after selling out during the quarter.
  • Emerald Advisers sold 2,362,834 DocGo shares in Q1 2024, an estimated $13.2M.
  • Emerald Advisers first reported a position in DocGo in Q4 2021 and held it in 9 quarters.
  • Emerald Advisers's DocGo position peaked at $21.2M in Q2 2023.
  • 134 funds tracked by Wall St. Rank held DocGo as of Q1 2024.

Based on Emerald Advisers's 13F filing for Q1 2024, filed 8 May 2024.